The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Open accessAbstract
CD38 (Cluster of Differentiation 38) is a multifunctional ecto-enzyme that metabolizes NAD+ and mediates nicotinamide dinucleotide (NAD+) and extracellular nucleotide homeostasis as well as intracellular calcium. CD38 is also an emerging therapeutic target under conditions in which metabolism is altered including infection, aging, and tumorigenesis. We describe multiple enzymatic activities of CD38, which may explain the breadth of biological roles observed for this enzyme. Of greatest significance is the role of CD38 as an ecto-enzyme capable of modulating extracellular NAD+ precursor availability: 1 to bacteria unable to perform de novo synthesis of NAD+; and 2 in aged parenchyma impacted by the accumulation of immune cells during the process of 'inflammaging'. We also discuss the paradoxical role of CD38 as a modulator of intracellular NAD+, particularly in tumor immunity. Finally, we provide a summary of therapeutic approaches to CD38 inhibition and 'NAD+ boosting' for treatment of metabolic dysfunction observed during aging and in tumor immunity. The present review summarizes the role of CD38 in nicotinamide nucleotide homeostasis with special emphasis on the role of CD38 as an immunomodulator and druggable target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Transfer of mitochondria from astrocytes to neurons after stroke
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., & Lo, E. H. (2016) · Nature · doi:10.1038/nature18928 · Cited by 1,423
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,179
Mitochondrial transfer between cells can rescue aerobic respiration
Spees, J. L., Olson, S. D., Whitney, M. J., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510511103 · Cited by 1,137
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506348 · Cited by 1,117 · cited 2×
“These antibody-based therapies, however, differ in their ability to induce direct apoptosis, mount complementmediated cytotoxicity (CDC), inhibit CD38 directly, and induce antibody-dependent cell-mediated phagocytosis (ADCP) (Table 1) (76, 96).”
Backgroundde Weers, M., Tai, Y.-T., van der Veer, M. S., Bakker, J. M., Vink, T., Jacobs, D. C. H., Oomen, L. A., Peipp, M., Valerius, T., Slootstra, J. W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003032 · Cited by 1,037
Immunology of the Maternal-Fetal Interface
Erlebacher, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100003 · Cited by 982
Novel Markers to Delineate Murine M1 and M2 Macrophages
Jablonski, K. A., Amici, S. A., Webb, L. M., Ruiz-Rosado, J. D. D., Popovich, P. G., Partida-Sanchez, S., & Guerau-de-Arellano, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145342 · Cited by 978
Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901
Self-citationEvolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., & Aydin, S. (2008) · Physiological Reviews · doi:10.1152/physrev.00035.2007 · Cited by 862
Tan, A. S., Baty, J. W., Dong, L.-F., Bezawork-Geleta, A., Endaya, B., Goodwin, J., Bajzikova, M., Kovarova, J., Peterka, M., Yan, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.003 · Cited by 785
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Yi, M., Jiao, D., Xu, H., Liu, Q., Zhao, W., Han, X., & Wu, K. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0864-3 · Cited by 764
Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., & Kiess, W. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.117 · Cited by 708
Targeting senescent cells alleviates obesity-induced metabolic dysfunction
Palmer, A. K., Xu, M., Zhu, Y., Pirtskhalava, T., Weivoda, M. M., Hachfeld, C. M., Prata, L. G., van Dijk, T. H., Verkade, E., Casaclang‐Verzosa, G., et al. (2019) · Aging Cell · doi:10.1111/acel.12950 · Cited by 658
Self-citationEssuman, K., Summers, D. W., Sasaki, Y., Mao, X., DiAntonio, A., & Milbrandt, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.022 · Cited by 619
Pasquier, J., Guerrouahen, B. S., Al Thawadi, H., Ghiabi, P., Maleki, M., Abu-Kaoud, N., Jacob, A., Mirshahi, M., Galas, L., Rafii, S., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-94 · Cited by 502
CD38 antibodies in multiple myeloma: back to the future
van de Donk, N. W. C. J., Richardson, P. G., & Malavasi, F. (2018) · Blood · doi:10.1182/blood-2017-06-740944 · Cited by 493
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Chen, L., Diao, L., Yang, Y., Yi, X., Rodriguez, B. L., Li, Y., Villalobos, P. A., Cascone, T., Liu, X., Tan, L., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1033 · Cited by 462 · cited 3×
“Themechanism by which CD38mediated PD-1/PD-L1 blockade resistance likely includes perturbation of adenosine receptor signaling in tumor microenvironment leading to immune modulation (87).”
BackgroundInfluentialPartida-Sánchez, S., Cockayne, D. A., Monard, S., Jacobson, E. L., Oppenheimer, N., Garvy, B., Kusser, K., Goodrich, S., Howard, M., Harmsen, A., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1209 · Cited by 450
ADP-ribosyl Cyclase and CD38 Catalyze the Synthesis of a Calcium-mobilizing Metabolite from NADP+
Aarhus, R., Graeff, R. M., Dickey, D. M., Walseth, T. F., & Hon, C. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30327 · Cited by 416
Nijhof, I. S., Casneuf, T., van Velzen, J., van Kessel, B., Axel, A. E., Syed, K., Groen, R. W. J., van Duin, M., Sonneveld, P., Minnema, M. C., et al. (2016) · Blood · doi:10.1182/blood-2016-03-703439 · Cited by 393
Tarragó, M. G., Chini, C. C. S., Kanamori, K. S., Warner, G. M., Caride, A., de Oliveira, G. C., Rud, M., Samani, A., Hein, K. Z., Huang, R., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.016 · Cited by 384
Self-citationA high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in Cockayne syndrome
Scheibye-Knudsen, M., Mitchell, S. J., Fang, E. F., Iyama, T., Ward, T., Wang, J., Dunn, C. A., Singh, N., Veith, S., Hasan-Olive, M. M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.005 · Cited by 352
Regulation of intracellular levels of NAD: A novel role for CD38
Aksoy, P., White, T. A., Thompson, M., & Chini, E. N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.042 · Cited by 351
Self-citationDeckert, J., Wetzel, M.-C., Bartle, L. M., Skaletskaya, A., Goldmacher, V. S., Vallée, F., Zhou-Liu, Q., Ferrari, P., Pouzieux, S., Lahoute, C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0695 · Cited by 333
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38
Escande, C., Nin, V., Price, N. L., Capellini, V., Gomes, A. P., Barbosa, M. T., O’Neil, L., White, T. A., Sinclair, D. A., & Chini, E. N. (2013) · Diabetes · doi:10.2337/db12-1139 · Cited by 332
Self-citationDong, L.-F., Kovarova, J., Bajzikova, M., Bezawork-Geleta, A., Svec, D., Endaya, B., Sachaphibulkij, K., Coelho, A. R., Sebkova, N., Ruzickova, A., et al. (2017) · eLife · doi:10.7554/elife.22187 · Cited by 297
Horenstein, A. L., Chillemi, A., Zaccarello, G., Bruzzone, S., Quarona, V., Zito, A., Serra, S., & Malavasi, F. (2013) · OncoImmunology · doi:10.4161/onci.26246 · Cited by 279
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
Chatterjee, S., Daenthanasanmak, A., Chakraborty, P., Wyatt, M. W., Dhar, P., Selvam, S. P., Fu, J., Zhang, J., Nguyen, H., Kang, I., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.006 · Cited by 270
CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma
Marlein, C. R., Piddock, R. E., Mistry, J. J., Zaitseva, L., Hellmich, C., Horton, R. H., Zhou, Z., Auger, M. J., Bowles, K. M., & Rushworth, S. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0773 · Cited by 264
Feng, X., Zhang, L., Acharya, C., An, G., Wen, K., Qiu, L., Munshi, N. C., Tai, Y.-T., & Anderson, K. C. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3192 · Cited by 252
NAD Deficiency, Congenital Malformations, and Niacin Supplementation
Shi, H., Enriquez, A., Rapadas, M., Martin, E. M. M. A., Wang, R., Moreau, J., Lim, C. K., Szot, J. O., Ip, E., Hughes, J. N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616361 · Cited by 246
Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q.-H., Xu, Y.-Y., Shang, D., & Hao, C.-M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040385 · Cited by 238
SIRT2 induces the checkpoint kinase BubR1 to increase lifespan
North, B. J., Rosenberg, M. A., Jeganathan, K. B., Hafner, A. V., Michan, S., Dai, J., Baker, D. J., Cen, Y., Wu, L. E., Sauve, A. A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201386907 · Cited by 238
Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
Wang, Y., Wang, H., Yao, H., Li, C., Fang, J.-Y., & Xu, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00536 · Cited by 209
NAD and the aging process: role in life, death and everything in between
Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208
Self-citationMetabolic Alterations in Aging Macrophages: Ingredients for Inflammaging?
van Beek, A. A., Van den Bossche, J., Mastroberardino, P. G., de Winther, M. P. J., & Leenen, P. J. M. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.007 · Cited by 207
Chini, E. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185788 · Cited by 189
Self-citationLu, J., Zheng, X., Li, F., Yu, Y., Chen, Z., Liu, Z., Wang, Z., Xu, H., & Yang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.14695 · Cited by 185
Krejcik, J., Frerichs, K. A., Nijhof, I. S., van Kessel, B., van Velzen, J. F., Bloem, A. C., Broekmans, M. E. C., Zweegman, S., van Meerloo, J., Musters, R. J. P., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2027 · Cited by 176
Aksoy, P., Escande, C., White, T. A., Thompson, M., Soares, S., Benech, J. C., & Chini, E. N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.066 · Cited by 173
Self-citationActivating T regulatory cells for tolerance in early pregnancy — the contribution of seminal fluid
Robertson, S. A., Guerin, L. R., Moldenhauer, L. M., & Hayball, J. D. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.08.003 · Cited by 171
The Membrane-Bound Enzyme CD38 Exists in Two Opposing Orientations
Zhao, Y. J., Lam, C. M. C., & Lee, H. C. (2012) · Science Signaling · doi:10.1126/scisignal.2002700 · Cited by 170
Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer
Inoue, Y., Yoshimura, K., Kurabe, N., Kahyo, T., Kawase, A., Tanahashi, M., Ogawa, H., Inui, N., Funai, K., Shinmura, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14434 · Cited by 169
Martin, T., Baz, R., Benson, D. M., Lendvai, N., Wolf, J., Munster, P., Lesokhin, A. M., Wack, C., Charpentier, E., Campana, F., et al. (2017) · Blood · doi:10.1182/blood-2016-09-740787 · Cited by 166
Grozio, A., Sociali, G., Sturla, L., Caffa, I., Soncini, D., Salis, A., Raffaelli, N., De Flora, A., Nencioni, A., & Bruzzone, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470435 · Cited by 158
Chini, C. C. S., Guerrico, A. M. G., Nin, V., Camacho-Pereira, J., Escande, C., Barbosa, M. T., & Chini, E. N. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0150 · Cited by 149
Self-citationChini, E. N., Beers, K. W., & Dousa, T. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3216 · Cited by 147
Self-citationChini, C., Hogan, K. A., Warner, G. M., Tarragó, M. G., Peclat, T. R., Tchkonia, T., Kirkland, J. L., & Chini, E. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.199 · Cited by 138
Self-citationHaffner, C. D., Becherer, J. D., Boros, E. E., Cadilla, R., Carpenter, T., Cowan, D., Deaton, D. N., Guo, Y., Harrington, W., Henke, B. R., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm502009h · Cited by 137
Naik, J., Themeli, M., de Jong-Korlaar, R., Ruiter, R. W. J., Poddighe, P. J., Yuan, H., de Bruijn, J. D., Ossenkoppele, G. J., Zweegman, S., Smit, L., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.192757 · Cited by 131
Why NAD + Declines during Aging: It’s Destroyed
Schultz, M. B., & Sinclair, D. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.022 · Cited by 126
Sauve, A. A., Munshi, C. B., Lee, H. C., & Schramm, V. L. (1998) · Biochemistry · doi:10.1021/bi981248s · Cited by 120
Matalonga, J., Glaría, E., Bresque, M., Escande, C., Carbo, J. M. C. I., Kiefer, K., Vicente, R., León, T. E., Beceiro, S., Pascual-García, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.007 · Cited by 119
Self-citationNAD+-Metabolizing Ectoenzymes in Remodeling Tumor–Host Interactions: The Human Myeloma Model
Horenstein, A. L., Chillemi, A., Quarona, V., Zito, A., Roato, I., Morandi, F., Marimpietri, D., Bolzoni, M., Toscani, D., Oldham, R. J., et al. (2015) · Cells · doi:10.3390/cells4030520 · Cited by 118
NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1
Aguilar-Arnal, L., Katada, S., Orozco-Solis, R., & Sassone-Corsi, P. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2990 · Cited by 117
Soares, S. M., Thompson, M., White, T. A., Isbell, A., Yamasaki, M., Prakash, Y. S., Lund, F. E., Galione, A., & Chini, E. N. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00638.2005 · Cited by 107
Self-citationImai, S. (2016) · npj Systems Biology and Applications · doi:10.1038/npjsba.2016.18 · Cited by 105
Flavonoids as inhibitors of human CD38
Kellenberger, E., Kuhn, I., Schuber, F. J., & Muller‐Steffner, H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.022 · Cited by 104
Horenstein, A. L., Quarona, V., Toscani, D., Costa, F., Chillemi, A., Pistoia, V., Giuliani, N., & Malavasi, F. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00198 · Cited by 100
Shu, B., Ye, F., Gui, Y., Lu, Q., Wei, W., Xue, X., Sun, X., He, W., Yang, J., & Dai, C. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.10.014 · Cited by 100
Higashida, H., Lopatina, O., Yoshihara, T., Pichugina, Y. A., Soumarokov, A. A., Munesue, T., Minabe, Y., Kikuchi, M., Ono, Y., Korshunova, N., et al. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01976.x · Cited by 98
Chini, E. N., Chini, C. C. S., Kato, I., Takasawa, S., & OKAMOTO, H. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620125 · Cited by 96
Self-citationMusso, T., Deaglio, S., Franco, L., Calosso, L., Badolato, R., Garbarino, G. M., Dianzani, U., & Malavasi, F. (2001) · PubMed · Cited by 95
Musso, T., Deaglio, S., Franco, L., Calosso, L., Badolato, R., Garbarino, G. M., Dianzani, U., & Malavasi, F. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.605 · Cited by 94
CD38 Controls the Innate Immune Response against Listeria monocytogenes
Lischke, T., Heesch, K., Schumacher, V., Schneider, M., Haag, F., Koch-Nolte, F., & Mittrücker, H.-W. (2013) · Infection and Immunity · doi:10.1128/iai.00340-13 · Cited by 92
Deaglio, S., Aydin, S., Grand, M. M., Vaisitti, T., Bergui, L., D'Arena, G. F., Chiorino, G., & Malavasi, F. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00146 · Cited by 92
The role of regulatory T cells in alloantigen tolerance
Aluvihare, V. R., & Betz, A. G. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00408.x · Cited by 89
Assi, R. E., Kantarjian, H. M., Ravandi, F., & Daver, N. G. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000401 · Cited by 85
CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells
Bu, X., Kato, J., Hong, J. A., Merino, M. J., Schrump, D. S., Lund, F. E., & Moss, J. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx137 · Cited by 78
Higashida, H., Yokoyama, S., Huang, J., Liu, L., Ma, W., Akther, S., Higashida, C., Kikuchi, M., Minabe, Y., & Munesue, T. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.030 · Cited by 75
Kang, B., Tirumurugaan, K. G., Deshpande, D. A., Amrani, Y., Panettieri, R. A., Walseth, T. F., & Karman, M. S. (2006) · The FASEB Journal · doi:10.1096/fj.05-4585fje · Cited by 73
The Roles of Oxytocin and CD38 in Social or Parental Behaviors
Lopatina, O. L., Ивановна, И. А., Salmina, A. B., & Higashida, H. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00182 · Cited by 72
Inhibition of glioma progression by a newly discovered CD38 inhibitor
Blacher, E., Baruch, B. B., Levy, A., Geva, N., Green, K. D., Garneau‐Tsodikova, S., Fridman, M., & Stein, R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29095 · Cited by 71
Cd38 Gene Knockout Juvenile Mice: A Model of Oxytocin Signal Defects in Autism
Higashida, H., Yokoyama, S., Munesue, T., Kikuchi, M., Minabe, Y., & Lopatina, O. L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1369 · Cited by 71
Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H)
Boslett, J., Hemann, C., Zhao, Y. J., Lee, H.-C., & Zweier, J. L. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239459 · Cited by 69
Lin, W. K., Bolton, E. L., Cortopassi, W. A., Wang, Y., O’Brien, F., Maciejewska, M., Jacobson, M. P., Garnham, C., Ruas, M., Parrington, J., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.789347 · Cited by 67
Chini, E. N., & Dousa, T. P. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1485 · Cited by 66
Self-citationCytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels
Liu, J., Zhao, Y. J., Li, W. H., Hou, Y. N., Li, T., Zhao, Z. Y., Fang, C., Li, S. L., & Lee, H. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703718114 · Cited by 63
Bahri, R., Bollinger, A., Bollinger, T., Orinska, Z., & Bulfone‐Paus, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045234 · Cited by 61
Seminal CD38 is a pivotal regulator for fetomaternal tolerance
Kim, B., Choi, Y.-M., Rah, S., Park, D., Park, S.-A., Chung, Y., Park, S.-M., Park, J. K., Jang, K. Y., & Kim, U. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413493112 · Cited by 60
Liu, Q., Graeff, R. M., Kriksunov, I. A., Jiang, H., Zhang, B., Oppenheimer, N. J., Lin, H., Potter, B. V. L., Lee, H. C., & Hao, Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031005 · Cited by 59
Shrimp, J. H., Hu, J., Dong, M., Wang, B. S., MacDonald, R. J., Jiang, H., Hao, Q., Yen, A., & Lin, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411046j · Cited by 56
Becherer, J. D., Boros, E. E., Carpenter, T. Y., Cowan, D. J., Deaton, D. N., Haffner, C. D., Jeune, M. R., Kaldor, I. W., Poole, J. C., Preugschat, F., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00992 · Cited by 55
Slow-binding inhibition of NAD+ glycohydrolase by arabino analogues of beta-NAD.
Muller‐Steffner, H., Malver, O., Hosie, L., Oppenheimer, N. J., & Schuber, F. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50133-8 · Cited by 53
Gul, R., Park, D., Shawl, A. I., Im, S.-Y., Nam, T., Lee, S. H., Ko, J.-K., Jang, K. Y., Kim, D., & Kim, U. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149125 · Cited by 49
Lopatina, O. L., Liu, H.-X., Amina, S., Hashii, M., & Higashida, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.012 · Cited by 46
Golden‐Mason, L., Curry, M. P., Nolan, N. P., Traynor, O., McEntee, G., Kelly, J., Hegarty, J. E., & O’Farrelly, C. (2000) · Hepatology · doi:10.1053/jhep.2000.7713 · Cited by 44
Williams, A. C., Hill, L. J., & Ramsden, D. B. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/302875 · Cited by 43
Slama, J. T., & Simmons, A. M. (1988) · Biochemistry · doi:10.1021/bi00401a028 · Cited by 42
CD38 is methylated in prostate cancer and regulates extracellular NAD+
Mottahedeh, J., Haffner, M. C., Grogan, T., Hashimoto, T., Crowell, P. D., Beltran, H., Sboner, A., Bareja, R., Esopi, D., Isaacs, W. B., et al. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0186-3 · Cited by 42
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia
Manna, A., Aulakh, S., Jani, P., Ahmed, S., Akhtar, S., Coignet, M. V., Heckman, M. G., Meghji, Z., Bhatia, K., Sharma, A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3412 · Cited by 41
Self-citationBurel, J. G., Apte, S. H., Groves, P., Klein, K., McCarthy, J. S., & Doolan, D. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005839 · Cited by 37
Schiavoni, I., Scagnolari, C., Horenstein, A. L., Leone, P., Pierangeli, A., Malavasi, F., Ausiello, C. M., & Fedele, G. (2017) · Immunology · doi:10.1111/imm.12873 · Cited by 36
Vitamin B3 in Health and Disease: Toward the Second Century of Discovery
Jacobson, M. K., & Jacobson, E. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8588-3_1 · Cited by 35
Zielinska, W., Barata, H., & Chini, E. N. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.08.033 · Cited by 34
Self-citationCatalysis-Based Inhibitors of the Calcium Signaling Function of CD38
Kwong, A. K., Chen, Z., Zhang, H., Leung, F. P., Lam, C. M. C., Ting, K. Y., Zhang, L., Hao, Q., Zhang, L., & Lee, H. C. (2011) · Biochemistry · doi:10.1021/bi201509f · Cited by 32
Utilization and Metabolism of NAD by Haemophilus parainfluenzae
Cynamon, M. H., Sorg, T. B., & Patapow, A. (1988) · Microbiology · doi:10.1099/00221287-134-10-2789 · Cited by 32
Mechanism-Based Inhibitors of CD38: A Mammalian Cyclic ADP-Ribose Synthetase
Sauve, A. A., & Schramm, V. L. (2002) · Biochemistry · doi:10.1021/bi0258795 · Cited by 30
Estrada-Figueroa, L. A., RAMÍREZ‐JIMÉNEZ, Y., Osorio‐Trujillo, C., Shibayama, M., Navarro‐García, F., García-Tovar, C. G., & Talamás‐Rohana, P. (2011) · Parasite Immunology · doi:10.1111/j.1365-3024.2011.01333.x · Cited by 27
A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver
Li, F., Wang, P., Liu, K., Tarragó, M. G., Lu, J. L., Chini, E. N., & Ma, X. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070920 · Cited by 25
Self-citationNicotinamide Ribosyl Uptake Mutants in Haemophilus influenzae
Herbert, M., Sauer, E., Smethurst, G. J., Kraiβ, A., Hilpert, A.-K., & Reidl, J. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5398-5401.2003 · Cited by 24
Zhang, S., Xue, X., Zhang, L., Zhang, L., & Liu, Z. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12606 · Cited by 21
The multi-faceted potential of CD38 antibody targeting in multiple myeloma
Shallis, R. M., Terry, C. M., & Lim, S. H. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-1990-2 · Cited by 20
Roepcke, S., Plock, N., Yuan, J. J., Fedyk, E. R., Lahu, G., Zhao, L., & Smithson, G. M. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.402 · Cited by 13
Cited by
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels
Chini, C. C. S., Peclat, T. R., Warner, G. M., Kashyap, S., Espindola-Netto, J. M., de Oliveira, G. C., Gomez, L. S., Hogan, K. A., Tarragó, M. G., Puranik, A. S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00298-z · Cited by 349
Self-citationCD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
Piedra-Quintero, Z. L., Wilson, Z., Nava, P., & Guerau-de-Arellano, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.597959 · Cited by 332
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Ostendorf, L., Burns, M., Durek, P., Heinz, G. A., Heinrich, F., Garantziotis, P., Enghard, P., Richter, U., Biesen, R., Schneider, U., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2023325 · Cited by 329
Evolving concepts in NAD+ metabolism
Chini, C. C. S., Zeidler, J. D., Kashyap, S., Warner, G., & Chini, E. N. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.003 · Cited by 288
Self-citation
Metadata
- Authors
- Hogan, K. A., Chini, C. C. S., & Chini, E. N.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-05-31
- Volume
- 10
- Pages
- 1187-1187
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2947902196
- Cited by
- 337
- References
- 110
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.